<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37-molecules-24-01552">
 <label>37.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Malaguarnera</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Bertino</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Chisari</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Motta</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vecchio</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vacante</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Caraci</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Greco</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Drago</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Nunnari</surname>
    <given-names>G.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Silybin supplementation during HCV therapy with pegylated interferon-Î± plus ribavirin reduces depression and anxiety and increases work ability</article-title>
  <source>BMC Psychiatry</source>
  <year>2016</year>
  <volume>16</volume>
  <elocation-id>398</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12888-016-1115-z</pub-id>
  <pub-id pub-id-type="pmid">27842532</pub-id>
 </element-citation>
</ref>
